SCHEMBL3017016

SCHEMBL3017016

CCOC(=O)c1[nH]c(C)nc1CC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.54
KDM4E B2RXH2 3/20 0.54
HPGD P15428 2/20 0.54
HTT P42858 1/20 0.54
RECQL P46063 1/20 0.54
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 2/20 0.41
PPARG P37231 1/20 0.41
NCOA2 Q15596 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
LMNA P02545 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPK1 P28482 1/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9310219 0.84 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL2616850 0.81 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL2257517 0.81 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL4356883 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL3023700 0.80 ALDH1A1 (0.49) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL7885220 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL6821625 0.79 HSD17B10 (0.36) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL948852 0.79 GABRP (0.41) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL24283847 0.79 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDHTTRECQL
SCHEMBL3022626 0.78 ALDH1A1 (0.47) ALDH1A1KDM4EHPGDHTTRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304419-B2 Chemical compounds GLAXOSMITHKLINE LLC (US) 2012-11-06 US disclosed
US-20100216746-A1 CHEMICAL COMPOUNDS GLAXOSMITHKLINE LLC (US) 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216746-A1 CHEMICAL COMPOUNDS SAMHD1, POLRMT, NUDT1 ALDH1A1 348/4885KDM4E 1070/4885HPGD 824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.